Conformation of a Bound Inhibitor of Blood Coagulant Factor Xa

Daniel R. Studelska,§ Lynda M. McDowell, Marc Adler, Robert D. O'Connor, Anil K. Mehta, William J. Guilford, Jerry L. Dallas, Damian Arnaiz, David R. Light, and Jacob Schaefer*
Department of Chemistry, Washington University, St. Louis, Missouri 63130, and Berlex Biosciences, 2600 Hilltop Drive, Richmond, California 94804
Biochemistry, 2003, 42 (26), pp 7942–7949
DOI: 10.1021/bi027369g
Publication Date (Web): June 17, 2003
Copyright © 2003 American Chemical Society

Abstract

13C{15N} and 13C{19F} rotational-echo double-resonance NMR have been used to characterize the enzyme-bound structure of ZK-816042, an amidine−imidazoline inhibitor of human factor Xa (FXa). The NMR experiments were performed on a lyophilized FXa−inhibitor complex. The complex was formed in solution in the presence of stabilizing excipients and frozen after gradual supercooling prior to lyophilization. The results indicate that the inhibitor binds with a distribution of orientations of the imidazoline ring.

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

Explore by:


Accession Codes

History

  • Published In Issue July 08, 2003
  • Received December 17, 2002
    Revised Manuscript Received April 7, 2003

Recommend & Share